Sound Bioventures
Swedensoundbioventures.com
Overview
Sound Bioventures is a venture capital fund investing in about-to-be clinical and clinical stage private companies in Europe and the USA developing novel medicines that addresses unmet medical needs. The fund focuses on companies with assets in clinical or about-to-be-clinical stage in primarily orphan and rare diseases. It leverages Scandinavian science to build companies and facilitate cross-Atlantic exchange of innovation, sector knowledge and capital.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cytospire Therapeutics | May 2026 | Series A | Co-investor |
| ARTHEx Biotech | Sep 2025 | Series B | Co-investor |
| AnaCardio | Jan 2025 | Series A Extension | Lead |
| Artax Biopharma | Aug 2024 | Convertible Debt | Co-investor |
| Theolytics | Apr 2024 | VC Round | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.